Thank you, Mr. Chair.
And thank you, folks, for some well-thought-out presentations.
Larry mentioned earlier the tour we did last week. One of the difficulties in the whole area of biotechnology is a lot of people out there think biotech is GMO exclusively, and it's anything but. Yes, there's the GMO debate and the non-GMO debate.
I take it from all your presentations, including yours, Jodi, that everyone believes we have to move to require a low-level-presence agreement in terms of markets. Is that correct?